ZAI LAB LIMITED
Income Statement
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.2M | $46.7M | $44.0M | $43.1M | $36.9M | $20.1M | $15.1M | $14.7M |
| Cost of Revenue | $17.4M | $15.6M | $21.7M | $12.2M | $10.9M | $7.5M | $6.8M | $4.9M |
| Gross Profit | $30.8M | $31.1M | $22.3M | $30.9M | $26.1M | $12.6M | $8.3M | $9.7M |
| Gross Margin | 63.9% | 66.5% | 50.6% | 71.8% | 70.6% | 62.7% | 54.8% | 66.3% |
| Operating Expenses | ||||||||
| Research & Development | $66.1M | $53.9M | $172.1M | $55.1M | $142.2M | $203.9M | $62.6M | $58.1M |
| SG&A Expense | $63.4M | $57.0M | $69.6M | $59.0M | $54.4M | $35.8M | $41.0M | $27.9M |
| Operating Income | $-98.7M | $-79.8M | $-219.2M | $-83.2M | $-170.6M | $-227.1M | $-95.3M | $-76.3M |
| Operating Margin | -204.9% | -170.7% | -498.6% | -193.0% | -461.8% | -1,129.6% | -631.1% | -520.5% |
| Interest Expense | — | — | — | — | — | — | $24.0K | $43.0K |
| Pretax Income | $-137.9M | $-82.2M | $-212.4M | $-96.1M | $-162.9M | $-233.1M | $-77.2M | $-63.5M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
| Net Income | $-137.9M | $-82.4M | $-211.8M | $-96.4M | $-163.3M | $-232.9M | $-76.5M | $-63.7M |
| Net Margin | -286.3% | -176.3% | -481.8% | -223.7% | -442.2% | -1,158.6% | -507.1% | -435.1% |
| EPS (Basic) | $-0.14 | $-0.09 | $-2.22 | $-0.10 | $-0.18 | $-0.26 | $-0.88 | $-0.84 |
| EPS (Diluted) | $-0.14 | $-0.09 | $-2.22 | $-0.10 | $-0.18 | $-0.26 | $-0.88 | $-0.84 |
| Shares Outstanding (Basic) | 957.7M | 955.5M | 955.0M | 950.4M | 930.5M | 88.5M | 87.8M | — |
| Shares Outstanding (Diluted) | 957.7M | 955.5M | 955.0M | 950.4M | 930.5M | 88.5M | 87.8M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |